As with any HTS, HIVST needs to provide a pathway to appropriate HIV treatment, care and prevention services. Because no single test, including HIVST, can provide an HIV‐positive diagnosis, all individuals with reactive HIVST results must receive further testing by a trained provider before initiating antiretroviral therapy (ART). Measuring linkage to ART is important to demonstrate programme effectiveness and impact, however, monitoring linkage after HIVST can be challenging because of its private nature. We highlight key challenges in measuring linkage to treatment and care following HIVST and suggest pragmatic approaches to addressing these in low‐income settings that routinely offer HIVST.
AUTHORS: Augustine T Choko, Muhammad S Jamil, Peter MacPherson, Elizabeth Corbett, Lastone Chitembo, Heather Ingold, Elkin Bermudez Aza, Marc d’Elbee, Meghan DiCarlo, Mohammed Majam, Tanya Shewchuk, Vincent Wong, Rachel Baggaley, Cheryl Johnson and on behalf of the World Health Organization HIV self testing technical working group